Skip to main content

Navidea Biopharmaceuticals Inc (OP: NAVB )

0.0005 UNCHANGED
Streaming Delayed Price Updated: 12:54 PM EST, Nov 4, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
April 25, 2019
Form 8-K
Source: SEC/Edgar
April 18, 2019
Form 8-K
Source: SEC/Edgar
April 07, 2019
Form 8-K
Source: SEC/Edgar
March 24, 2019
Form 8-K
Source: SEC/Edgar
March 06, 2019
Form 8-K
Source: SEC/Edgar
February 20, 2019
Form 8-K
Source: SEC/Edgar
January 31, 2019
Form S-8
Source: SEC/Edgar
December 20, 2018
Form 8-K
Source: SEC/Edgar
November 29, 2018
Form 8-K
Source: SEC/Edgar
November 27, 2018
Form 8-K
Source: SEC/Edgar
November 06, 2018
Form 8-K
Source: SEC/Edgar
November 01, 2018
Form 8-K
Source: SEC/Edgar
October 29, 2018
Form 8-K
Source: SEC/Edgar
October 08, 2018
Form 8-K
Source: SEC/Edgar
October 04, 2018
Form SC 13G
Source: SEC/Edgar
September 23, 2018
Form 8-K
Source: SEC/Edgar
September 16, 2018
Form 8-K
Source: SEC/Edgar
August 20, 2018
Form 8-K
Source: SEC/Edgar
August 15, 2018
Form DEFA14A
Source: SEC/Edgar
August 15, 2018
Form 8-K
Source: SEC/Edgar
August 15, 2018
Form 8-K
Source: SEC/Edgar
August 14, 2018
Form 8-K
Source: SEC/Edgar
August 08, 2018
Form DEFA14A
Source: SEC/Edgar
July 19, 2018
Form DEF 14A
Source: SEC/Edgar
July 08, 2018
Form PRE 14A
Source: SEC/Edgar
June 06, 2018
Form SD
Source: SEC/Edgar
May 30, 2018
Form 8-K
Source: SEC/Edgar
May 07, 2018
Form 8-K
Source: SEC/Edgar
April 03, 2018
Form 8-K
Source: SEC/Edgar
April 01, 2018
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.